EVT.DE : Summary for EVOTEC AG O.N. - Yahoo Finance

U.S. Markets open in 5 hrs 27 mins

Evotec AG (EVT.DE)


XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
7.33+0.01 (+0.19%)
As of 9:45AM CET. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close7.32
Open7.33
Bid7.33 x 105300
Ask7.35 x 169300
Day's Range7.26 - 7.38
52 Week Range2.96 - 7.99
Volume73,538
Avg. Volume1,086,713
Market Cap1.06B
Beta0.11
PE Ratio (TTM)56.38
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Evotec AG breached its 50 day moving average in a Bearish Manner : EVT-DE : February 24, 2017
    Capital Cube4 days ago

    Evotec AG breached its 50 day moving average in a Bearish Manner : EVT-DE : February 24, 2017

    Categories: Europe Stock Alerts Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Evotec AG. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Evotec AG breached its 50 day moving average in a Bullish Manner : EVT-DE : February 13, 2017
    Capital Cube15 days ago

    Evotec AG breached its 50 day moving average in a Bullish Manner : EVT-DE : February 13, 2017

    Categories: Europe Stock Alerts Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Evotec AG. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • PR Newswire2 months ago

    Brown Gibbons Lang and Company (BGL) Advises in the Sale of Preclinical ADME-Toxicology Services Provider Cyprotex PLC

    CHICAGO, Jan. 11, 2017 /PRNewswire/ -- Brown Gibbons Lang & Company (BGL) is pleased to announce the sale of Cyprotex PLC (AIM:CRX) to Evotec AG (EVT.DE). Evotec acquired 100 percent of the outstanding shares of Cyprotex in an all-cash transaction valued at £55.7 million effective December 15, 2016. With the acquisition, Evotec will strengthen its high-end drug discovery platform and capabilities with access to the market's most industrialized ADME-Tox platform and proven expertise in in vitro ADME screening, mechanistic and high-content toxicology screening, and predictive modeling.